A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus
Clinical trial NCT02443506 · COMPLETED
Trial details
- NCT number
- NCT02443506
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-04-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.